Previous 10 | Next 10 |
TARRYTOWN, N.Y., April 17, 2023 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN ) today announced that P. Roy Vagelos, M.D., will retire from his role as Chair of the Company’s Board of Directors and will not stand for reelection at the Company’s 2023 Annual Me...
New subgroup data and further analyses of the aflibercept 8 mg clinical trial program to highlight durability results of extended dosing intervals, patient characteristics, and efficacy and safety in wet age-related macular degeneration and diabetic macular edema 18 presentations reinfo...
2023-04-16 01:22:24 ET Summary Regeneron's Dupixent reported a 30% reduction in COPD exacerbation at week 52, while ensifentrine reported a 36% and 42% reduction in the ENHANCE-1 and ENHANCE-2 trials, respectively. Ensifentrine's broader inclusion criteria and lower cost as a smal...
2023-04-14 05:32:00 ET Ghana became the first country globally to approve a new malaria vaccine developed by the Oxford University, BBC reported. Ghana's Food and Drugs Authority approved the vaccine, dubbed R21, for use in children between five months to three years old. The Africa...
2023-04-13 11:54:32 ET Intellia Therapeutics ( NASDAQ: NTLA ) added ~12% Thursday after Canaccord Genuity launched its coverage with a Buy rating and a $66 per share target citing the biotech's expertise in the CRISPR-Cas9 gene editing technology. In 2021, Intellia ( NTLA ...
2023-04-13 06:12:29 ET Summary Shares of Regeneron jumped to new all-time highs following the successful phase 3 results of Dupixent in COPD. COPD could be a $3 billion or greater a year opportunity for Dupixent and should push its peak sales well above $20 billion by the end of t...
2023-04-12 17:10:09 ET Piper Sandler technician Craig Johnson said Wednesday that the S&P 500 ( SP500 ) is poised for a rebound once the market works through the negative sentiment that has dominated trading lately. As part of this, he predicted a rise of 11% from present level...
2023-04-12 02:26:28 ET Summary The White House's announcement on drug price caps caused a significant drop in biopharma stocks during Q1 2023. The impact of drug pricing-related caps and pressure will likely be limited, and the industry is expected to adapt and find new revenue st...
2023-04-10 22:25:44 ET The U.S. government is launching a $5B-plus program to accelerate the development of new coronavirus vaccines and treatments, officials from the Biden administration and the Department of Health and Human Services ( HHS ) confirmed Monday. An HHS official said...
2023-04-10 08:26:10 ET Summary GSK's dividend yield is 3.58%, slightly higher than Bristol-Myers Squibb's 3.22%. Bristol-Myers Squibb's total debt was about $40.8 billion at the end of 2022, down $4.78 billion from the previous year, thanks to the successful integration of Celgene...
News, Short Squeeze, Breakout and More Instantly...
Regeneron Pharmaceuticals Inc. Company Name:
REGN Stock Symbol:
NASDAQ Market:
Regeneron Pharmaceuticals Inc. Website:
A look at the top 10 most actives in the United States Qualigen Therapeutics Inc. (QLGN) rose 111.4% to $0.4341 on volume of 412,713,755 shares Maxeon Solar Technologies Ltd. (MAXN) fell 1.3% to $0.2375 on volume of 280,800,277 shares NVIDIA Corporation (NVDA) rose 1.4% to $129.24 on volu...
2024-07-12 11:00:05 ET Trung Huynh from UBS issued a price target of $1,250.00 for REGN on 2024-07-12 10:18:00. The adjusted price target was set to $1,250.00. At the time of the announcement, REGN was trading at $1092.3075. The overall price target consensus is at $902....
A look at the top 10 most actives in the United States Maxeon Solar Technologies Ltd. (MAXN) rose 3.6% to $0.2493 on volume of 118,503,418 shares Qualigen Therapeutics Inc. (QLGN) rose 94.8% to $0.4 on volume of 100,863,101 shares AgriFORCE Growing Systems Ltd. (AGRI) rose 20.0% to $0.098...